Cargando…
Combinatorial Versus Individual Gene Pharmacogenomic Testing in Mental Health: A Perspective on Context and Implications on Clinical Utility
Pharmacogenomic testing in mental health has not yet reached its full potential. An important reason for this involves differentiating individual gene testing (IGT) from a combinatorial pharmacogenomic (CPGx) approach. With IGT, any given gene reveals specific information that may, in turn, pertain...
Autores principales: | Winner, Joel G., Dechairo, Bryan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654186/ https://www.ncbi.nlm.nih.gov/pubmed/26604861 |
Ejemplares similares
-
The clinical validity and utility of combinatorial pharmacogenomics: Enhancing patient outcomes
por: Benitez, Joachim, et al.
Publicado: (2015) -
Use of combinatorial pharmacogenomic testing in two cases from community psychiatry
por: Fields, Eve S, et al.
Publicado: (2016) -
Canadian Medication Cost Savings Associated with Combinatorial Pharmacogenomic Guidance for Psychiatric Medications
por: Tanner, Julie-Anne, et al.
Publicado: (2019) -
Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial
por: Tiwari, Arun K., et al.
Publicado: (2022) -
Correction: Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial
por: Tiwari, Arun K., et al.
Publicado: (2022)